← Evidence map

ArticleCancers2021

CRISPR-to-Kill (C2K)-Employing the Bacterial Immune System to Kill Cancer Cells.

Dawid Głów et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34944926